125 related articles for article (PubMed ID: 29868833)
1. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy.
Hoffman RM; Brummel SS; Britto P; Pilotto JH; Masheto G; Aurpibul L; Joao E; Purswani MU; Buschur S; Pierre MF; Coletti A; Chakhtoura N; Klingman KL; Currier JS;
Clin Infect Dis; 2019 Jan; 68(2):273-279. PubMed ID: 29868833
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy.
Theron G; Brummel S; Fairlie L; Pinilla M; McCarthy K; Owor M; Chinula L; Makanani B; Violari A; Moodley D; Chakhtoura N; Browning R; Hoffman R; Fowler MG
Clin Infect Dis; 2021 Jul; 73(2):e312-e320. PubMed ID: 32564058
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy.
Hoffman RM; Warshaw MG; Amico KR; Pilotto J; Masheto G; Achalapong J; Machado E; Chokephaibulkit K; Duarte G; João E; Graham KK; Knapp KM; Stek AM; Scott GB; Coletti A; Loftis AJ; Chakhtoura N; Currier JS;
J Acquir Immune Defic Syndr; 2020 Jan; 83(1):72-80. PubMed ID: 31651545
[TBL] [Abstract][Full Text] [Related]
5. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
6. Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
Caniglia EC; Zash R; Jacobson DL; Diseko M; Mayondi G; Lockman S; Chen JY; Mmalane M; Makhema J; Hernán MA; Shapiro RL
AIDS; 2018 Jan; 32(1):113-120. PubMed ID: 29112066
[TBL] [Abstract][Full Text] [Related]
7. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Gaolethe T; Petlo C; Lockman S; Holmes LB; Makhema J; Shapiro RL
Lancet Glob Health; 2018 Jul; 6(7):e804-e810. PubMed ID: 29880310
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.
Currier JS; Britto P; Hoffman RM; Brummel S; Masheto G; Joao E; Santos B; Aurpibul L; Losso M; Pierre MF; Weinberg A; Gnanashanmugam D; Chakhtoura N; Klingman K; Browning R; Coletti A; Mofenson L; Shapiro D; Pilotto J;
PLoS One; 2017; 12(5):e0176009. PubMed ID: 28489856
[TBL] [Abstract][Full Text] [Related]
10. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy.
Stringer EM; Kendall MA; Lockman S; Campbell TB; Nielsen-Saines K; Sawe F; Cu-Uvin S; Wu X; Currier JS
PLoS One; 2018; 13(7):e0199555. PubMed ID: 30020964
[TBL] [Abstract][Full Text] [Related]
12. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
BJOG; 2016 May; 123(6):910-6. PubMed ID: 26269220
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
Santosa WB; Staines-Urias E; Tshivuila-Matala COO; Norris SA; Hemelaar J
AIDS; 2019 Aug; 33(10):1623-1633. PubMed ID: 30932959
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors and preterm delivery: another piece in the puzzle.
Favarato G; Townsend CL; Bailey H; Peters H; Tookey PA; Taylor GP; Thorne C
AIDS; 2018 Jan; 32(2):243-252. PubMed ID: 29135577
[TBL] [Abstract][Full Text] [Related]
15. Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):359-64. PubMed ID: 25469525
[TBL] [Abstract][Full Text] [Related]
16. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
17. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
19. Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Selph SS; Bougatsos C; Dana T; Grusing S; Chou R
JAMA; 2019 Jun; 321(23):2349-2360. PubMed ID: 31184704
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]